论文部分内容阅读
目的：探讨经左胸小切口联合管状胃切除术治疗食管癌的临床疗效。方法分析了2010年1月～2012年12月我院收治的88例食管癌患者的临床资料，随机分为观察组和对照组，观察组采用经左胸小切口联合管状胃切除术治疗，对照组采用常规开胸手术治疗。比较两组临床指标改善及术后并发症发生率情况。结果观察组患者手术时间，开胸出血量，胸腔引流量及住院时间均少（短）于对照组，两组比较差异有统计学意义（P＜0.05）。观察组VAS疼痛评分总优良率(93.18%)明显高于对照组(61.36%)，差异有统计学意义（P＜0.05）。观察组患者术后并发症发生率（9.09%）明显低于对照组（29.55%），差异有统计学意义（P＜0.05）。结论经左胸小切口联合管状胃切除术治疗食管癌的临床疗效较好，此手术具有创伤性小，恢复快和术后并发症低等优点，值得临床推广应用。“,”objective to investigate the left chest smal incision combined tubular gastrectomy clinical curative effect for the treatment of esophageal cancer. Method is analyzed from January 2010 to December 2010, our hospital clinical data of 88 patients with esophageal cancer, were randomly divided into observation group and control group, the observation group USES the left chest smal incision with tubular gastrectomy therapy, the control group with conventional open thoracic surgery. Compare two groups of clinical indicators improved and the incidence of postoperative complications. Results in the observation group, operation time, thoracic hemorrhage, drainage and hospitalization time were less (short) in the control group, there was significant difference between two groups (P < 0.05). The observation group VAS pain scores were excelent and good rate (93.18%) was significantly higher than the control group (61.36%), the difference was statisticaly significant (P < 0.05). Patients in the observation group the incidence of postoperative complications (9.09%) was significantly lower than the control group (29.55%), the difference was statisticaly significant (P < 0.05). A better clinical effect conclusion through left thoracic smal incision combined with tubular gastrectomy in the treatment of esophageal carcinoma, the operation is traumatic smal, restore fast and postoperative complications is low, it is worthy of clinical application.